http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-035064-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-915 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
| filingDate | 2001-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-035064-A1 |
| titleOfInvention | 3- (1-METHYL-3-INDOLIL) -4- (1-METHYL-6-NITRO-3-INDOLIL) -1H-PIRROL-2,5-DIONA, AMORPHALLY, PROCESSES TO PREPARE IT, PHARMACEUTICAL COMPOSITION THAT THE UNDERSTAND AND USE OF SUCH COMPOUND IN THE MANUFACTURE OF MEDICINES |
| abstract | 3- (1-methyl-3-indolyl) -4- (1-methyl-6-nitro-3-indolyl) -1H-pyrrole-2,5-dione of formula (1), in amorphous form, which is substantially free of the crystalline compound. Said amorphous compound is pharmaceutically active as a cell cycle inhibitor and is therefore used in the treatment of cancerous tumors. In addition, processes for its preparation, pharmaceutical compositions comprising it, and the use of such a compound in the manufacture of medicaments are disclosed. |
| priorityDate | 2000-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5327686 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426075222 |
Total number of triples: 16.